-
Oral Dextran Microgels for Local Colon Cancer Therapy
2026-08-18
The reference study develops a sequentially targeted oral system that combines dextran microgels with cisplatin- and SPION-loaded lipid nanoparticles for localized colon cancer treatment. Its design uses colon-associated enzymatic degradation, folate-receptor recognition, and alternating magnetic field activation to coordinate drug release, cellular uptake, chemotherapy, and magnetothermal therapy while potentially limiting systemic exposure.
-
Fluo-4 AM for Podocyte Calcium Signaling Assays
2026-08-17
Fluo-4 AM provides a bright, cell-permeant readout for real-time intracellular calcium dynamics, making it useful for podocyte signaling and high-throughput functional assays. This guide translates the GPR107 diabetic nephropathy findings into practical calcium-imaging workflows, assay controls, and troubleshooting decisions.
-
IR-1061 H-Aggregation for NIR-II Cancer Therapy
2026-08-17
Yu et al. developed RRIALP-C4, an anionic liposome that co-delivers IR-1061 and carboplatin while using RR9-mediated membrane fusion to transfer H-aggregated fluorophore into tumor cell membranes. The resulting platform combines NIR-II fluorescence imaging with NIR-I photothermal therapy and temperature-sensitive chemotherapy release, providing a formulation-level strategy for image-guided synergistic cancer treatment.
-
Lyso-Tracker Red for Reliable Live-Cell Assays
2026-08-16
Learn how Lyso-Tracker Red, SKU B8814, can resolve common interpretation and workflow problems in cell viability, proliferation, and cytotoxicity studies. This scenario-based guide covers live-cell compatibility, protocol control, fluorescence interpretation, and practical vendor selection.
-
Betaine Hydrochloride for Inflammation Assays
2026-08-15
Learn how to use Betaine hydrochloride as a controlled matrix variable, enzyme-assay reagent, and exploratory cell culture supplement when building inflammation-focused workflows. The guide connects practical reagent handling with the TLR4/NF-κB/NLRP3 findings reported in esophageal cancer research without overstating what the compound has been shown to do.
-
Mitoxantrone HCl: From Mechanism to Assay Design
2026-08-14
Mitoxantrone HCl is a DNA topoisomerase II inhibitor with applications that extend from DNA-damage biology to estrogen-receptor degradation. This guide translates its dual mechanisms into practical assay decisions for leukemia, stem-cell, multiple sclerosis, and pancreatic cancer research.
-
N-octanoyl-L-Homoserine lactone: Host Signaling
2026-08-14
N-octanoyl-L-Homoserine lactone (C8-HSL) is more than a quorum-sensing standard: it is a precise perturbation tool for connecting bacterial communication with host-cell signaling. This guide translates recent lung cancer findings into better assay design, controls, and interpretation.
-
Bifendate, Autophagy, and Hepatic Lipid Accumulation
2026-08-13
The reference study shows that bifendate inhibits autophagy at several mechanistically distinct stages, including autophagosome–lysosome fusion, lysosome acidification, and autophagic lysosome reformation. It also reports reduced oleic acid-induced lipid droplet accumulation, linking bifendate activity to lysosomal regulation and hepatocellular lipid handling rather than to antioxidant effects alone.
-
6-FAM SE for Assay Design and Nanomedicine Readouts
2026-08-13
6-FAM SE enables durable amine-directed labeling of DNA, proteins, and peptides. This article explains how its reaction chemistry can guide assay design and analytical readouts for emerging nanomedicine platforms, without confusing tracer validation with therapeutic efficacy.
-
DiD (DiDC 18 (5)) for Membrane Tracking
2026-08-12
DiD (DiDC 18 (5)) combines red-shifted imaging with rapid lipophilic membrane labeling for macrophage morphology, cell migration tracking, and immunofluorescence workflows. This practical guide connects membrane-resolved assays with a ROS-responsive diabetic periodontitis platform while clearly separating validated product specifications from protocol starting points.
-
Sulfamonomethoxine Toxicity in Five Aquatic Species
2026-08-12
Huang and colleagues evaluated sulfamonomethoxine toxicity across algae, cladocerans, and medaka, combining acute and chronic endpoints in a multi-trophic design. The results identify microalgae as the most sensitive tested group and support closer assessment of antibiotic residues released from aquaculture and livestock systems.
-
CD28–ARS2–PKM Splicing in CD8+ T Cells
2026-08-11
Holling and colleagues identify a CD28–ARS2 signaling axis that reshapes alternative splicing in activated CD8+ T cells, favoring PKM2 over PKM1 and enabling flexible glucose metabolism. The work links RNA processing to interferon-γ production and antitumor activity while showing that this metabolic branch can operate independently of canonical CD28–PI3K signaling.
-
WSP-5 for H2S Live-Cell Imaging Workflows
2026-08-11
WSP-5 combines rapid turn-on fluorescence with H2S selectivity for real-time live-cell imaging, donor-release studies, and disease-relevant assays. This practical guide covers sample preparation, imaging parameters, cardiovascular translation, cancer cell model imaging, and troubleshooting.
-
Mitoxantrone HCl: DNA Damage Assay Workflow
2026-08-10
Mitoxantrone HCl combines DNA topoisomerase II inhibition with a newly described ERα-targeting activity, making it useful for separating genotoxicity, receptor degradation, apoptosis, and cell-cycle effects. This guide translates those mechanisms into reproducible cell-based workflows for oncology, stem-cell, and immune research.
-
ML365: From TASK1 Mechanism to Translation
2026-08-09
A translational analysis of ML365 that connects TASK1 ion-channel biology with hippocampal NLRP3 signaling, postoperative cognitive impairment, assay strategy, and evidence-aware experimental design.